Long reads
How to become a science entrepreneur
Five tips from the experts on going it alone
Amplifying intelligent drug design
This year’s Chemistry World Entrepreneur of the year is Andrew Hopkins of start-up Exscientia and the University of Dundee, UK
Access to drugs: a failure of pharma?
Many people around the world are either unable to afford the drugs they need, or their conditions have not been addressed by pharma R&D. Sarah Houlton investigates
Profiles
The glue entrepreneurs
The business novices who launched global sticky success Sugru
Amplifying intelligent drug design
This year’s Chemistry World Entrepreneur of the year is Andrew Hopkins of start-up Exscientia and the University of Dundee, UK
Expanding precision medicine beyond cancer
Exclusive interview with Koustubh Ranade, vice president of R&D at MedImmune
Taming vaccines with chemistry
Vaxxilon aims to simplify vaccine development by replacing biological components with well-defined synthetic molecules
Opinion
(+)-Pleuromutilin
Total synthesis is sometimes the only way to explore the chemical space around a natural product
Making enough of a difference
What if the needle in the drug development haystack ends up being too small to be useful?
What's holding back continuous manufacturing?
Despite manay advantages, the move to flow chemistry in fine and speciality chemicals is slow
Unpicking a clinical trial death
A new study shows up off-target effects of a drug that proved deadly, and highlights the pitfalls of drug discovery
More Business News
Celgene and BeiGene agree cancer partnership
Immuno-oncology deal sees firms exchange licensing rights for antibody drugs
Silence Therapeutics and Alnylam in patent dispute
Suit alleges competitors need to license Silence patents relating to their drug cantidates
Ukraine plans to privatise state chemical producers
Government aims to develop struggling industry by attracting foreign investment
GM corn growers win US lawsuit against Syngenta
Kansas jury awards over $217m damages to farmers in the first of eight trials
FDA asks Endo to take pain drug off market
Request part of larger strategy to address opioid misuse in the US
Explosion kills 10 at Chinese petrochemical plant
Nine others injured when gas tanker exploded in loading area
European Commission to investigate excessive drug pricing
Inquiry covers claims that Aspen Pharma’s price rises on five cancer treatments were unjustified
Huntsman and Clariant agree merger deal
GE accused of exposing workers to toxic chemicals
Seattle Genetics cancels Immunomedics deal
Pollution from Indian drugmakers drives drug resistance
Patheon buyout brings Thermo into contract manufacturing
Avantor to buy VWR for $6.4bn
Merck KGaA to buy Chematica
J&J fights talc cancer claims
US Steel plant spills chromium into waterway
Russia invests in speciality chemicals industry
